AMN Healthcare stock falls 1.82 percent as recovery cools

Published on 09/23/2026 at 22:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

AMN Healthcare stock stood at USD 33.91 on September 23, 2026, after a 128.44 percent year to date gain. Q2 adjusted EPS reached USD 0.77 versus USD 0.30.

AMN, US0017441017, Illustration mit AI erstellt.

AMN Healthcare Services stock (ISIN US0017441017) stood at USD 33.91 on the NYSE on September 23, 2026, down USD 0.63 or 1.82 percent from the previous close. The move follows a 128.44 percent year to date gain, making the latest pullback a test of whether the recovery can extend.

Q2 revenue beat guidance

AMN reported USD 673 million in consolidated revenue for Q2 2026, up 2 percent from the prior-year quarter and 6 percent above the high end of its guidance range, according to The Globe and Mail.

The earnings quality was mixed across the portfolio. Nurse and Allied Solutions generated USD 422 million of revenue, up 11 percent year over year, while Physician and Leadership Solutions declined 6 percent to USD 165 million and Technology and Workforce Solutions fell 15 percent to USD 87 million.

Adjusted EPS strengthens sharply

Adjusted EPS reached USD 0.77 in Q2 2026, compared with USD 0.30 in the year-ago quarter, according to The Globe and Mail. That increase contrasts with the smaller 2 percent revenue gain and points to margin, mix and one-time items as the more important drivers of the quarter.

Labor disruption revenue totaled USD 25 million, versus a USD 10 million assumption in the Q2 guidance. The USD 15 million difference helped the company exceed its internal revenue target, while the transcript also identified USD 27 million of nonrecurring revenue benefits from billing true-ups and reserve adjustments.

Stock remains below yearly high

AMN Healthcare stock was USD 3.31 below its 52-week high of USD 37.22 on September 23, 2026, a gap of 8.89 percent. The share price remains USD 18.94 above its 52-week low of USD 14.97, while the company carried a market capitalization of USD 1,315,235,023.

The reference price was USD 33.91 on the NYSE on September 23, 2026 at 4:00 p.m. ET. The 1.82 percent daily decline sits against the stronger Q2 operating comparison, leaving the next market test centered on whether Nurse and Allied growth can offset weakness in the other segments.